The worldwide market for blood glucose monitoring is mainly dependent on the number of diabetes patients in the world which is growing significantly and is expected to grow even further in the near future. As a result, the worldwide market for glucose monitoring devices should also grow. There is no cure for diabetes and it can only be controlled. In order to control it, blood glucose monitoring is mandatory.
MarketreportsOnline.com - Global Glucose Monitoring Market Report 2012 Published: March 2012 No. of Pages: 39 Price: Single User: US $ 800 Corporate User: US $ 1600 The worldwide market for blood glucose monitoring is mainly dependent on the number of diabetes patients in the world which is growing significantly and is expected to grow even further in the near future. As a result, the worldwide market for glucose monitoring devices should also grow. There is no cure for diabetes and it can only be controlled. In order to control it, blood glucose monitoring is mandatory. Diabetes can be of 2 types i.e. type I and type II. Type II diabetes is so far more prevalent compared to type I. The type I diabetes can be monitored with the help of regular glucose monitoring devices and self monitoring blood glucose monitoring devices. Regular glucose monitoring is done with the help of standard hand prick glucose monitors. This segment contributes the major share of total sales of blood glucose monitoring industry. The blood glucose test strips which are required for glucose tests are disposable which means there is a steady growth opportunity in the glucose test strip market. Continuous glucose monitoring is mainly required for type I diabetes patients or patients very high blood glucose level. A type I diabetes is less prevalent; the market for CGM (Continuous glucose monitoring) devices is smaller compared to Regular glucose monitoring market. CGM is a costlier procedure and is not covered automatically by medical insurances which also affect the sales of this particular segment. CGM is an invasive procedure and operation is required to place the sensor in the patient’s body. As soon as the reimbursement of CGM improves, the market should perform better. The global aging population, obese population, worldwide health expenditure and awareness about diabetes are the factors which are fuelling the growth of the glucose monitoring industry. The unwillingness of patients in frequent glucose test and increased competition in the developed market are the major challenges to the growth. The report provides an analysis of the glucose monitoring market. It also discusses the major trends, growth drivers and challenges in the market. The regular glucose monitoring market is mainly controlled by four major players namely Roche, J&J-Lifescan, Bayer and Abbott whereas the CGM market is controlled by Medtronic and Dexcom. By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the global glucose monitoring devices market. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests. Global Glucose Monitoring Market 2012 Table of Contents 1. Glucose Monitoring 2. Glucose Monitoring - Market Size 3. Glucose Monitoring Market by Segments 4. Key Trends 5. Market Drivers 6. Challenges 7. Significant Developments 8. Competitive Landscape 9. Company Profiles 9.1 Johnson & Johnson 9.2 Abbott Lab 9.3 Roche 9.4 Bayer AG 10. Market Outlook List of Charts List of Tables
Pages to are hidden for
"MarketreportsOnline.com - Global Glucose Monitoring Market Report 2012"Please download to view full document